Effect of Acupressure on Health-Related Quality of Life in Patients with Polycystic Ovarian Syndrome: A Randomized Clinical Trial.
Journal
Evidence-based complementary and alternative medicine : eCAM
ISSN: 1741-427X
Titre abrégé: Evid Based Complement Alternat Med
Pays: United States
ID NLM: 101215021
Informations de publication
Date de publication:
2022
2022
Historique:
received:
21
12
2021
accepted:
18
05
2022
entrez:
16
6
2022
pubmed:
17
6
2022
medline:
17
6
2022
Statut:
epublish
Résumé
The present study was conducted to determine the effect of acupressure on health-related quality of life in patients with polycystic ovary syndrome. This study was a double-blind, randomized clinical trial with a control group. Ninety-six patients with polycystic ovary syndrome from Mofateh gynecological clinic in Yasuj in Iran were enrolled according to the inclusion criteria. Patients were randomly assigned to intervention and control groups. In the intervention group, pressure on the points, Ren3, Ren4, Liv3, Sp6, and Sp10 and in the control group, pressure on sham points were performed for 6 weeks (2 sessions per week). The primary outcome was health-related quality of life, measured by the modified polycystic ovary syndrome health-related quality of life questionnaire (MPCOSQ). The secondary outcomes were total testosterone levels and clinical symptoms in patients with polycystic ovary syndrome. The outcome variables were measured before the intervention at week 0 (baseline) and after the intervention at week 18 (12 weeks after the end of intervention). The results indicated that at week 18, the score of clinical symptoms and the total testosterone level of the intervention group were lower than those of the control group. The health-related quality of life score in the intervention group was higher than that in the control group, which was statistically significant (
Identifiants
pubmed: 35707478
doi: 10.1155/2022/2920132
pmc: PMC9192291
doi:
Types de publication
Journal Article
Langues
eng
Pagination
2920132Informations de copyright
Copyright © 2022 Marzieh Nekooi et al.
Déclaration de conflit d'intérêts
The authors declare that there are no conflicts of interest regarding the publication of this paper.
Références
Evid Based Complement Alternat Med. 2013;2013:493038
pubmed: 23533489
Zhongguo Zhen Jiu. 2009 Feb;29(2):99-102
pubmed: 19391530
J Clin Endocrinol Metab. 1961 Nov;21:1440-7
pubmed: 13892577
Br J Dermatol. 1977 Sep;97(3):247-54
pubmed: 921894
Iran J Reprod Med. 2013 Sep;11(9):753-60
pubmed: 24639816
J Tradit Chin Med. 2016 Apr;36(2):151-9
pubmed: 27400468
Nat Rev Endocrinol. 2016 Feb;12(2):74-5
pubmed: 26729036
J Clin Endocrinol Metab. 2003 Dec;88(12):5801-7
pubmed: 14671172
Evid Based Complement Alternat Med. 2007 Dec;4(4):409-17
pubmed: 18227907
Iran J Nurs Midwifery Res. 2018 Jan-Feb;23(1):8-13
pubmed: 29344039
Evid Based Complement Alternat Med. 2013;2013:762615
pubmed: 24073009
Am J Obstet Gynecol. 2008 Feb;198(2):166.e1-8
pubmed: 18226614
J Clin Endocrinol Metab. 1998 Jun;83(6):1976-87
pubmed: 9626128
Int J Nurs Stud. 2004 Jan;41(1):99-106
pubmed: 14670399
Hum Reprod. 2004 Jan;19(1):41-7
pubmed: 14688154
Hum Reprod. 2012 Sep;27(9):2729-36
pubmed: 22740491
Obes Sci Pract. 2016 Dec;2(4):426-435
pubmed: 28090348
Evid Based Complement Alternat Med. 2011;2011:612464
pubmed: 21799683
Expert Rev Pharmacoecon Outcomes Res. 2007 Dec;7(6):597-603
pubmed: 20528321
Am J Physiol Endocrinol Metab. 2013 May 1;304(9):E934-43
pubmed: 23482444
BMC Complement Altern Med. 2006 Jul 07;6:25
pubmed: 16824230
BMC Complement Altern Med. 2013 Jun 13;13:131
pubmed: 23763822
J Pain Symptom Manage. 2011 Oct;42(4):589-603
pubmed: 21531533
BMC Public Health. 2008 Aug 19;8:292
pubmed: 18710578
Reprod Biol Endocrinol. 2011 Mar 25;9:39
pubmed: 21435276
Complement Ther Med. 2017 Oct;34:10-15
pubmed: 28917360
Am J Physiol Endocrinol Metab. 2011 Jan;300(1):E37-45
pubmed: 20943753
Hum Reprod. 2009 Jun;24(6):1446-51
pubmed: 19223290
Gynecol Endocrinol. 2006 Feb;22(2):80-6
pubmed: 16603432